Azapeptides as CD36 binding compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9115171
APP PUB NO 20130203686A1
SERIAL NO

13829797

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An azapeptide compound of Formula I:

description='In-line Formulae' end='lead'A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa′)b-B  I.description='In-line Formulae' end='tail'

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VALORISATION-RECHERCHE LIMITED PARTNERSHIPMONTRÉAL QUÉBEC H3T 1P1

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boeglin, Damien Ostwald, FR 7 64
Chemtob, Sylvain Cote St-Luc, CA 27 151
Lubell, William Montreal, CA 8 230
Ong, Huy Ville Mont-Royal, CA 9 6
Proulx, Caroline Montreal, CA 4 2
Sabatino, David Montreal, CA 4 6
Sajjadi, Zohreh Schenectady, US 3 2
Sennlaub, Florian Paris, FR 16 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00